Hemolytic uremic syndrome: how do factor H mutants mediate endothelial damage?
- 1 July 2001
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 22 (7) , 345-348
- https://doi.org/10.1016/s1471-4906(01)01972-x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Factor H Mutations in Hemolytic Uremic Syndrome Cluster in Exons 18–20, a Domain Important for Host Cell RecognitionAmerican Journal of Human Genetics, 2001
- Clustering of Missense Mutations in the C-Terminal Region of Factor H in Atypical Hemolytic Uremic SyndromeAmerican Journal of Human Genetics, 2001
- Each of the Three Binding Sites on Complement Factor H Interacts with a Distinct Site on C3bJournal of Biological Chemistry, 2000
- Complement Factor H Gene Mutation Associated with Autosomal Recessive Atypical Hemolytic Uremic SyndromeAmerican Journal of Human Genetics, 2000
- Factor H and disease: a complement regulator affects vital body functionsMolecular Immunology, 1999
- Genetic studies into inherited and sporadic hemolytic uremic syndromeKidney International, 1998
- Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency.Journal of Clinical Investigation, 1995
- Interferon gamma induces synthesis of complement alternative pathway proteins by human endothelial cells in culture.The Journal of Experimental Medicine, 1988
- Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H.Proceedings of the National Academy of Sciences, 1987
- Hemolytic Uremic Syndrome in FamiliesNew England Journal of Medicine, 1975